Suppr超能文献

药物的抗氧化作用。药物选择的依据?

Drug antioxidant effects. A basis for drug selection?

作者信息

Halliwell B

机构信息

Pulmonary Medicine, UC Davis Medical Center, Sacramento.

出版信息

Drugs. 1991 Oct;42(4):569-605. doi: 10.2165/00003495-199142040-00003.

Abstract

A free radical is any species capable of independent existence that contains one or more unpaired electrons. Free radical reactions have been implicated in the pathology of more than 50 human diseases. Radicals and other reactive oxygen species are formed constantly in the human body, both by deliberate synthesis (e.g. by activated phagocytes) and by chemical side-reactions. They are removed by enzymic and nonenzymic antioxidant defence systems. Oxidative stress, occurring when antioxidant defences are inadequate, can damage lipids, proteins, carbohydrates and DNA. A few clinical conditions are caused by oxidative stress, but more often the stress results from the disease. Sometimes it then makes a significant contribution to the disease pathology, and sometimes it does not. Several antioxidants are available for therapeutic use. They include molecules naturally present in the body [superoxide dismutase (SOD), alpha-tocopherol, glutathione and its precursors, ascorbic acid, adenosine, lactoferrin and carotenoids] as well as synthetic antioxidants [such as thiols, ebselen (PZ51), xanthine oxidase inhibitors, inhibitors of phagocyte function, iron ion chelators and probucol]. The therapeutic efficacy of SOD, alpha-tocopherol and ascorbic acid in the treatment of human disease is generally unimpressive to date although dietary deficiencies of the last two molecules should certainly be avoided. Xanthine oxidase inhibitors may be of limited relevance as antioxidants for human use. Exciting preliminary results with probucol (antiatherosclerosis), ebselen (anti-inflammatory), and iron ion chelators (in thalassaemia, leukaemia, malaria, stroke, traumatic brain injury and haemorrhagic shock) need to be confirmed by controlled clinical trials. Clinical testing of N-acetylcysteine in HIV-1-positive subjects may also be merited. A few drugs already in clinical use may have some antioxidant properties, but this ability is not widespread and drug-derived radicals may occasionally cause significant damage.

摘要

自由基是任何能够独立存在且含有一个或多个未配对电子的物种。自由基反应与50多种人类疾病的病理学有关。自由基和其他活性氧物种在人体内不断形成,既通过有意合成(如通过活化的吞噬细胞),也通过化学副反应。它们通过酶促和非酶促抗氧化防御系统被清除。当抗氧化防御不足时发生的氧化应激会损害脂质、蛋白质、碳水化合物和DNA。一些临床病症是由氧化应激引起的,但更常见的是应激源于疾病。有时它会对疾病病理学产生重大影响,有时则不会。有几种抗氧化剂可用于治疗。它们包括体内天然存在的分子[超氧化物歧化酶(SOD)、α-生育酚、谷胱甘肽及其前体、抗坏血酸、腺苷、乳铁蛋白和类胡萝卜素]以及合成抗氧化剂[如硫醇、依布硒啉(PZ51)、黄嘌呤氧化酶抑制剂、吞噬细胞功能抑制剂、铁离子螯合剂和普罗布考]。尽管肯定应避免后两种分子的饮食缺乏,但迄今为止,SOD、α-生育酚和抗坏血酸在治疗人类疾病方面的疗效总体上并不显著。黄嘌呤氧化酶抑制剂作为人类使用的抗氧化剂可能相关性有限。普罗布考(抗动脉粥样硬化)、依布硒啉(抗炎)和铁离子螯合剂(用于地中海贫血、白血病、疟疾、中风、创伤性脑损伤和失血性休克)令人兴奋的初步结果需要通过对照临床试验来证实。对HIV-1阳性受试者进行N-乙酰半胱氨酸的临床试验也可能值得一试。一些已在临床使用的药物可能具有一些抗氧化特性,但这种能力并不普遍,而且药物衍生的自由基偶尔可能会造成重大损害。

相似文献

1

引用本文的文献

2
Biosynthesis of Strontium Nanoparticles Using and its Antioxidant Effect.利用[具体内容未给出]生物合成锶纳米颗粒及其抗氧化作用。
J Pharm Bioallied Sci. 2024 Apr;16(Suppl 2):S1330-S1334. doi: 10.4103/jpbs.jpbs_588_23. Epub 2024 Apr 16.
6
FoxO3 and oxidative stress: a multifaceted role in cellular adaptation.FoxO3 和氧化应激:细胞适应中的多方面作用。
J Mol Med (Berl). 2023 Feb;101(1-2):83-99. doi: 10.1007/s00109-022-02281-5. Epub 2023 Jan 4.

本文引用的文献

3
Vitamin C and iron.
N Engl J Med. 1981 Jan 15;304(3):170-1. doi: 10.1056/NEJM198101153040311.
7
Drug trial of superoxide dismutase in Duchenne's muscular dystrophy.
Arch Neurol. 1982 Jun;39(6):342-6. doi: 10.1001/archneur.1982.00510180020004.
9
Caeruloplasmin: physiological and pathological perspectives.铜蓝蛋白:生理与病理视角
Crit Rev Clin Lab Sci. 1981;14(4):257-329. doi: 10.3109/10408368109105866.
10
Chemical phototoxicity in humans.人类的化学光毒性。
J Natl Cancer Inst. 1982 Jul;69(1):265-8.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验